Publicaciones en las que colabora con Sylwia Michlewska (23)

2024

  1. A new class of polyphenolic carbosilane dendrimers binds human serum albumin in a structure-dependent fashion

    Scientific Reports, Vol. 14, Núm. 1

  2. Effect of polyphenolic dendrimers on biological and artificial lipid membranes

    Chemistry and Physics of Lipids, Vol. 265

  3. Polyphenolic dendrimers as carriers of anticancer siRNA

    International Journal of Pharmaceutics, Vol. 658

  4. Synthesis and biophysical evaluation of carbosilane dendrimers as therapeutic siRNA carriers

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study

    International Journal of Pharmaceutics, Vol. 636

  2. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  3. Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols

    Colloids and Surfaces B: Biointerfaces, Vol. 227

  4. Ruthenium metallodendrimer against triple-negative breast cancer in mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 53

2022

  1. Heterofunctionalized polyphenolic dendrimers decorated with caffeic acid: Synthesis, characterization and antioxidant activity

    Sustainable Materials and Technologies, Vol. 33

2021

  1. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

  2. Dendronized Gold Nanoparticles as Carriers for gp160 (HIV-1) Peptides: Biophysical Insight into Complex Formation

    Langmuir, Vol. 37, Núm. 4, pp. 1542-1550

  3. Evaluation of dendronized gold nanoparticles as siRNAs carriers into cancer cells

    Journal of Molecular Liquids, Vol. 324

  4. Interaction of cationic carbosilane dendrimers and their siRNA complexes with MCF-7 cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

  5. Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA

    Journal of Inorganic Biochemistry, Vol. 223

2020

  1. Copper (II) metallodendrimers combined with pro-apoptotic sirnas as a promising strategy against breast cancer cells

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-14

  2. Generation dependent effects and entrance to mitochondria of hybrid dendrimers on normal and cancer neuronal cells in vitro

    Biomolecules, Vol. 10, Núm. 3

  3. Ruthenium dendrimers against human lymphoblastic leukemia 1301 cells

    International Journal of Molecular Sciences, Vol. 21, Núm. 11, pp. 1-13

2019

  1. In vitro anticancer properties of copper metallodendrimers

    Biomolecules, Vol. 9, Núm. 4

  2. Ruthenium dendrimers against acute promyelocytic leukemia: In vitro studies on HL-60 cells

    Future Medicinal Chemistry, Vol. 11, Núm. 14, pp. 1741-1756

  3. Synthesis and characterization of FITC labelled ruthenium dendrimer as a prospective anticancer drug

    Biomolecules, Vol. 9, Núm. 9